Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Ocellaris Pharma, Inc.
Mayo Clinic
Universitair Ziekenhuis Brussel
University of Pittsburgh
Bicara Therapeutics
Numab Therapeutics AG
Revolution Medicines, Inc.
UNICANCER
The Center for Clinical and Cosmetic Research
Carisma Therapeutics Inc
The Center for Clinical and Cosmetic Research
Advaxis, Inc.
Pfizer
Charite University, Berlin, Germany
Revolution Medicines, Inc.
Fate Therapeutics
Institut de Cancérologie de Lorraine
Revolution Medicines, Inc.
University Health Network, Toronto
University of South Alabama
University Health Network, Toronto
Ontario Clinical Oncology Group (OCOG)
University of California, San Diego
The University of Texas Medical Branch, Galveston
Memorial Sloan Kettering Cancer Center
Emory University
Tufts Medical Center
UNICANCER